2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$387.16+$1.99 (+0.52%)
Price as of Jul 31, 2026 7:50 PM EDT- $209.2BMarket Cap
- 33.64%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$387.16+$1.99 (+0.52%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $385.16 | ||
Change | -$2.48 (-0.64%) | ||
Open | $382.00 | ||
High | $386.82 | ||
Low | $379.34 | ||
Previous Close | $387.64 | ||
Volume | 1,954,538 | ||
30-Day Average Volume | 2,350,400 | ||
1-Week Change | 2.43% | ||
1-Month Change | 6.36% | ||
1-Year Change | 33.64% | ||
3-Year Change | 80.37% | ||
5-Year Change | 86.65% | ||
Fundamentals | |||
Shares Outstanding | 539.7M | ||
Total Assets | $92.5B | ||
Market Cap | $209.2B | ||
Enterprise Value | $254.5B | ||
Period: QTR TTM FY | |||
Revenue | $8.2B | ||
Net Income | $1.8B | ||
Free Cash Flow | $1.5B | ||
EBIT | $2.7B | ||
EBITDA | $3.9B | ||
Net Working Capital | $6.5B | ||
EPS | $3.34 | ||
Enterprise Value/EBITDA | 66 | ||
Enterprise Value/Revenue | 31 | ||
P/B | 23 | ||
P/E | 115 | ||
PEG | 3 | ||
Price/Free Cash Flow | 141 | ||
Price/Operating Cash Flow | 95 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.62% | ||
Trailing Annual Dividend Yield | 2.54% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield